腎癌病例討論ppt課件(已改無錯字)
2023-02-05 17:19:58 本頁面
【正文】 et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a bined analysis. J Urol 2022 Mar。171(3):10716. (我是醫(yī)生 ) 文獻(xiàn)綜述 ? 轉(zhuǎn)移性腎細(xì)胞癌的手術(shù)治療 ? 轉(zhuǎn)移腫瘤的治療 Complete removal of metastatic lesions contributes to an improvement of clinical prognosis. 2022年歐洲腎細(xì)胞癌治療指南 (我是醫(yī)生 ) 文獻(xiàn)綜述 ? 轉(zhuǎn)移性腎細(xì)胞癌的手術(shù)治療 ? 轉(zhuǎn)移腫瘤的治療 ? 對于可以徹底切除的轉(zhuǎn)移腫瘤，需要手術(shù)治療 Flanigan RC, Mickisch G, Sylvester R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a bined analysis. J Urol 2022 Mar。171(3):10716. Ljungberg B, Landberg G, Alamdari FI. Factors of importance for prediction of survival in patients with metastatic renal cell carcinoma, treated with or without nephrectomy. Scand J Urol Nephrol 2022 Aug。34(4):24651. Pongracz N, Zimmerman R, Kotz R. Orthopaedic management of bony metastases of renal cancer. Semin Surg Oncol 1988。4(2):13942. Tongaonkar HB, Kulkarni JN, Kamat MR. Solitary metastases from renal cell carcinoma: a review. J Surg Oncol 1992 Jan。49(1):458. van der Poel HG, Roukema JA, Horenblas S, et al. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol 1999。35(3):197203 (我是醫(yī)生 )
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號-1